ERBB2 and lip and oral cavity carcinoma: There is only one systematic review and meta-analysis related to the prognostic implications of EGFR2 (ErbB2) overexpression in oral cancer, which reports its association with decreased survival and increased metastatic involvement of the neck lymph nodes [72].